Scholarlink

Background <p>Polycythemia vera (PV) is a chronic myeloproliferative neoplasm associated with an increased risk of thrombotic events, including stroke. Data on stroke characteristics among PV patients in the Middle East are limited.</p> Methods <p>We analyzed 113 polycythemia vera (PV) patients diagnosed between 2015 and 2023 at a tertiary center in the Middle East. Stroke cases were identified from a national perspective database and confirmed to have PV. Clinical and demographic characteristics, stroke subtypes, outcomes, and time to stroke were recorded and compared to PV patients without stroke.</p> Results <p>Stroke occurred in 14 patients (12.4%), predominantly ischemic. The mean age at stroke was 53.4 ± 10.2 years, with a male predominance (64.3%). The median time from PV diagnosis to stroke was 317 days (range: 11–3235 days). Despite relatively mild neurological deficits at presentation, median National Institute of Health Stroke Scale (NIHSS) of 3, mortality reached 21.4% and recurrent stroke occurred in 21.4% of cases.</p> Conclusion <p>Stroke is a frequent and early complication in PV, often occurring within the first year after diagnosis. Despite mild clinical presentation, mortality and recurrence rates are high. Early identification, dynamic risk stratification and aggressive management of vascular risk factors are critical to improving outcomes in this vulnerable population.Fethical</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Early and Recurrent Stroke in Polycythemia Vera Patients: Insight from Middle East Tertiary Cancer Center

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月9日

查看全文
  • Shehab F. Mohamed,
  • Abdulrahman F. Al-Mashdali,
  • Anas Babiker,
  • Ahmed Alsayed,
  • Abdalla Fadul,
  • Hana Qasim,
  • Samah Kohla,
  • Dina Soliman,
  • Sara Al Dali,
  • Hassan Magboul,
  • Kalpana Singh,
  • Fatima Al Ali,
  • Mohamed Yassin,
  • Yahia Imam

摘要

Background

Polycythemia vera (PV) is a chronic myeloproliferative neoplasm associated with an increased risk of thrombotic events, including stroke. Data on stroke characteristics among PV patients in the Middle East are limited.

Methods

We analyzed 113 polycythemia vera (PV) patients diagnosed between 2015 and 2023 at a tertiary center in the Middle East. Stroke cases were identified from a national perspective database and confirmed to have PV. Clinical and demographic characteristics, stroke subtypes, outcomes, and time to stroke were recorded and compared to PV patients without stroke.

Results

Stroke occurred in 14 patients (12.4%), predominantly ischemic. The mean age at stroke was 53.4 ± 10.2 years, with a male predominance (64.3%). The median time from PV diagnosis to stroke was 317 days (range: 11–3235 days). Despite relatively mild neurological deficits at presentation, median National Institute of Health Stroke Scale (NIHSS) of 3, mortality reached 21.4% and recurrent stroke occurred in 21.4% of cases.

Conclusion

Stroke is a frequent and early complication in PV, often occurring within the first year after diagnosis. Despite mild clinical presentation, mortality and recurrence rates are high. Early identification, dynamic risk stratification and aggressive management of vascular risk factors are critical to improving outcomes in this vulnerable population.Fethical